Treatment of the acquired immune deficiency syndrome.
The acquired immune deficiency syndrome (AIDS) and AIDS-related complex (ARC) are sequelae of immune system injury initiated by a novel human retrovirus [human T-lymphotrophic virus strain III/lymphadenopathy-associated virus (HTLV III/LAV)]. The resulting spectrum of immune deficiency sets the stage for opportunistic infection and malignancy. In this review, we consider progress made in the treatment and prevention of AIDS and HTLV III/LAV infection. Immunomodulator and antiviral approaches are discussed.
D000163:Acquired Immunodeficiency Syndrome / Q000276:immunology / Q000628:therapy*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D016026:Bone Marrow Transplantation; D003131:Combined Modality Therapy; D006801:Humans; D007167:Immunotherapy; D007372:Interferons / Q000627:therapeutic use; D007376:Interleukin-2 / Q000276:immunology; D017710:Lymphocyte Transfusion; D013498:Suramin / Q000627:therapeutic use; D013950:Thymus Gland / Q000637:transplantation; D014765:Viral Vaccines
D000911:Antibodies, Monoclonal; D000998:Antiviral Agents; D007376:Interleukin-2; D014765:Viral Vaccines; D013498:Suramin; D007372:Interferons